Desmopressin, Misoprostol, nor Carboprost Affect Platelet Aggregability Following Traumatic Brain Injury and Aspirin
Journal of Surgical Research · 2024
DOI: 10.1016/j.jss.2024.01.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Research, 2024. Verfasst von Matthew R Baucom und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Cincinnati, Cincinnati, Ohio. Hauptthemen laut MEDLINE: Carboprost, Misoprostol, Brain Injuries, Traumatic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
INTRODUCTION: Desmopressin (DDAVP) has been utilized clinically in patients taking aspirin (ASA) to improve drug-induced platelet dysfunction. Misoprostol and carboprost, prostaglandin analogs commonly used for postpartum hemorrhage, may also induce platelet aggregation. The aim of this study was to determine the effects of DDAVP, misoprostol, and carboprost administration on platelet aggregability following traumatic brain injury (TBI) in mice treated with ASA. METHODS: Male C57BL/6 mice were randomized into seven groups (n = 5 each): untouched, ASA only, Saline/TBI, ASA/TBI, ASA/TBI/DDAVP 0.4 μg/kg, ASA/TBI/misoprostol 1 mg/kg, and ASA/TBI/carboprost 100 μg/kg. TBI was induced via a weight drop model 4-h after ASA (50 mg/kg) gavage. Mice were given an intraperitoneal injection of DDAVP, misoprostol, or carboprost 10 minutes after TBI. In vivo testing was completed utilizing tail vein bleed. Mice were sacrificed 30-min posttreatment and blood was collected via cardiac puncture. Whole blood was analyzed via Multiplate impedance aggregometry, rotational thromboelastometry, and TEG6s. RESULTS: Mice receiving misoprostol after ASA/TBI demonstrated decreased tail vein bleeding times compared to ASA only treated mice. However, mice treated with misoprostol following ASA and TBI demonstrated decreased platelet aggregability compared to untouched mice and TBI only mice within the arachidonic acid agonist pathway. By contrast, DDAVP and carboprost did not significantly change platelet aggregability via adenosine diphosphate or arachidonic acid following ASA and TBI. However, DDAVP did decrease the platelet contribution to clot via rotational thromboelastometry. CONCLUSIONS: Reversal of medication-induced platelet inhibition has become increasingly controversial after TBI. Based on these results, DDAVP, misoprostol, nor carboprost consistently improve platelet aggregability following TBI in those also treated with ASA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Cincinnati, Cincinnati, Ohio.
- Department of Surgery, University of Cincinnati, Cincinnati, Ohio. Electronic address: michael.goodman@ucmail.uc.edu.
Förderung
- NIGMS NIH HHS
Zitieren
APA
Baucom, M. R., Price, A. D., Weissman, N., England, L., Schuster, R. M., Pritts, T. A., & Goodman, M. D. (2024). Desmopressin, Misoprostol, nor Carboprost Affect Platelet Aggregability Following Traumatic Brain Injury and Aspirin. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2024.01.027
Vancouver
Baucom MR, Price AD, Weissman N, England L, Schuster RM, Pritts TA, et al. Desmopressin, Misoprostol, nor Carboprost Affect Platelet Aggregability Following Traumatic Brain Injury and Aspirin. Journal of Surgical Research. 2024. doi:10.1016/j.jss.2024.01.027
BibTeX
@article{Baucom2024,
author = {Baucom, Matthew R and Price, Adam D and Weissman, Nicholas and England, Lisa and Schuster, Rebecca M and Pritts, Timothy A and Goodman, Michael D},
title = {Desmopressin, Misoprostol, nor Carboprost Affect Platelet Aggregability Following Traumatic Brain Injury and Aspirin},
journal = {Journal of Surgical Research},
year = {2024},
doi = {10.1016/j.jss.2024.01.027}
}
EUVIMED